Kiora Pharmaceuticals Inc (KPRX) — Cash Flow Quality Index
Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Quality Index of -47.49x as of September 2025. Operating cash flow of $-1.27 Million is below net income of $26.81K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Kiora Pharmaceuticals Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kiora Pharmaceuticals Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Kiora Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KPRX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Kiora Pharmaceuticals Inc (2024–2024)
Year-by-year earnings quality comparison for Kiora Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is Kiora Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.38x | $8.56 Million | $3.59 Million | — |